ONCOCROSS

  • ONCOCROSS

    • Mission

    • History

    • Leadership

    • Scientific Advisory Board

  • Technology

    • Platform

    • ONCO AI PArk

      • RAPTOR AI™

      • ONCO-RAPTOR AI™

      • ONCOfind AI™

    • in vitro / in vivo analysis

  • Collaboration

    • New Indication

    • Optimal Cancer Type Identification

    • CUP Primary Site Identification

  • Pipeline

  • News

    • Press

    • Update

CONTACT US
한
  • ONCOCROSS

    • Mission

    • History

    • Leadership

    • Scientific Advisory Board

  • Technology

    • Platform

    • ONCO AI PArk

      • RAPTOR AI™

      • ONCO-RAPTOR AI™

      • ONCOfind AI™

    • in vitro / in vivo analysis

  • Collaboration

    • New Indication

    • Optimal Cancer Type Identification

    • CUP Primary Site Identification

  • Pipeline

  • News

    • Press

    • Update

  • 한
  • EN
CONTACT US
  • Main
  • News
  • Press

Press

113 Posts
  • 머니투데이

    온코크로스, AI신약개발 'K-스타트업대상' 수상

    01-28-2021
  • 머니투데이

    온코크로스, '청년기업인상' 중소벤처기업부장관 표창

    12-22-2020
  • 헤럴드경제

    “바이오 히든챔피언 키운다”…中企-대기업 상생 생태계 구축

    11-27-2020
  • 헤럴드경제

    코로나19 백신·치료제 개발 ‘국내 바이오벤처’ 시간과 싸움중 [미래산업 플러스-바이오 히든챔피언 키운다]

    11-27-2020
  • 헬로디디

    암 환자 진료만 1만명, 현직 의사 'AI 신약벤처'로 도전장

    11-19-2020
  • 더벨

    AI 신약벤처 온코크로스, 기술특례 IPO 추진

    09-15-2020
  • Dealstreet Asia

    South Korean AI-based pharma firm Oncocross secures $14m Series B

    09-11-2020
  • AVCJ

    Korean AI drug developer secures $14m Series B

    09-10-2020
  • 더벨

    'AI신약연구' 온코크로스, VC업고 '제약 협업' 선도

    09-09-2020
  • Sina

    韩国AI新药企业Oncocross完成约1400万美元B轮融资

    09-08-2020
  • 매일경제

    `AI 신약벤처` 온코크로스, 165억 유치 성공

    09-07-2020
  • Merger Market

    Oncocross welcomes pre-IPO investors for AI drug development; mandates NH I&S for KOSDAQ listing

    09-04-2020
  • «
  • ‹
  • 6
  • 7
  • 8
  • 9
  • 10

Please enter a prompt

ONCOCROSS
CEO
KIM Yi Rang
Address
16F, 11, Saechang-ro, Mapo-gu, Seoul
Tel
02-867-9967
Fax
02-867-9968
Email
oncocross@oncocross.com
Terms & Conditions Privacy Policy Cookie Policy
ⓒ ONCOCROSS CO., LTD. All Rights Reserved.